APA

Schernthaner-Reiter M. H., Itariu B. K., Krebs M., Promintzer-Schifferl M., Stulnig T. M., Tura A., Anderwald C. H., Clodi M., Ludvik B., Pacini G., Luger A. & Vila G. (20191212). GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism. : Nutrition, metabolism, and cardiovascular diseases : NMCD.

Chicago

Schernthaner-Reiter M H, Itariu B K, Krebs M, Promintzer-Schifferl M, Stulnig T M, Tura A, Anderwald C H, Clodi M, Ludvik B, Pacini G, Luger A and Vila G. 20191212. GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism. : Nutrition, metabolism, and cardiovascular diseases : NMCD.

Harvard

Schernthaner-Reiter M. H., Itariu B. K., Krebs M., Promintzer-Schifferl M., Stulnig T. M., Tura A., Anderwald C. H., Clodi M., Ludvik B., Pacini G., Luger A. and Vila G. (20191212). GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism. : Nutrition, metabolism, and cardiovascular diseases : NMCD.

MLA

Schernthaner-Reiter M H, Itariu B K, Krebs M, Promintzer-Schifferl M, Stulnig T M, Tura A, Anderwald C H, Clodi M, Ludvik B, Pacini G, Luger A and Vila G. GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism. : Nutrition, metabolism, and cardiovascular diseases : NMCD. 20191212.